Literature DB >> 21480359

Depression and antiviral response to interferon-based therapy for hepatitis C virus infection.

Jennifer M Loftis, Benjamin J Morasco, Peter Hauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21480359      PMCID： PMC3074049          DOI： 10.1002/hep.24064

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.

Authors:  C Maddock; S Landau; K Barry; P Maulayah; M Hotopf; A J Cleare; S Norris; C M Pariante
Journal:  Mol Psychiatry       Date:  2005-04       Impact factor: 15.992

2.  Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.

Authors:  Peter Derek Christian Leutscher; Martin Lagging; Mads Rauning Buhl; Court Pedersen; Gunnar Norkrans; Nina Langeland; Kristine Mørch; Martti Färkkilä; Simon Hjerrild; Kristoffer Hellstrand; Per Bech
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

3.  Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.

Authors:  Charles L Raison; Sherry D Broadwell; Andrey S Borisov; Amita K Manatunga; Lucile Capuron; Bobbi J Woolwine; Ira M Jacobson; Charles B Nemeroff; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2005-01       Impact factor: 7.217

4.  Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.

Authors:  Stanley S Liu; Terry D Schneekloth; Jayant A Talwalkar; W Ray Kim; John J Poterucha; Michael R Charlton; Russell H Wiesner; John B Gross
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

5.  Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.

Authors:  Jennifer M Loftis; Robert E Socherman; Charles D Howell; Ashlee J Whitehead; Jo Ann Hill; Jason A Dominitz; Peter Hauser
Journal:  Neurosci Lett       Date:  2004-07-22       Impact factor: 3.046

6.  Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study.

Authors:  Donna M Evon; Darmendra Ramcharran; Steven H Belle; Norah A Terrault; Robert J Fontana; Michael W Fried
Journal:  Am J Gastroenterol       Date:  2009-09-29       Impact factor: 10.864

7.  Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder.

Authors:  Peter Hauser; Benjamin J Morasco; Alex Linke; Dannell Bjornson; Samantha Ruimy; Annette Matthews; Aly Rifai; David W Indest; Jennifer M Loftis
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386
  7 in total
  2 in total

Review 1.  Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications.

Authors:  Peter Hauser; Shira Kern
Journal:  World J Hepatol       Date:  2015-07-28

2.  Chemical constituents of tobacco smoke induce the production of interleukin-8 in human bronchial epithelium, 16HBE cells.

Authors:  Guojun Zhou; Weiqiang Xiao; Chengyun Xu; Yajun Hu; Xiaokai Wu; Fangfang Huang; Xinbo Lu; Chunyun Shi; Ximei Wu
Journal:  Tob Induc Dis       Date:  2016-07-19       Impact factor: 2.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.